Breast Implant PMA Timeframes Tested By Inamed “Not-Approvable” Letter

Firms seeking premarket approval for silicone breast implants should conduct tests designed to more closely predict rupture and gel bleed under real-world conditions, according to new FDA draft guidelines

More from Archive

More from Medtech Insight